Defunct Company
Total Trials
1
As Lead Sponsor
As Collaborator
0
Total Enrollment
150
NCT00847899
Evaluation of Soluble Epoxide Hydrolase (s-EH) Inhibitor in Patients With Mild to Moderate Hypertension and Impaired Glucose Tolerance
Phase: Phase 2
Role: Lead Sponsor
Start: Jan 31, 2009
Completion: Nov 30, 2009